The Fas/Fas Ligand System and Cancer: Immune Privilege and Apoptosis

By Abrahams Vikki M.   Kamsteeg Marijke   Mor Gil  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 19-30

Humana Press, Inc

Access to resources Recommend Favorite

Expression and Characterization of Biologically Active Human Fas Ligand Produced in CHO Cells

By Zappitelli Sabrina   D’Alatri Laura   Ciucci Alessandra   Raucci Giuseppe   Faiella Angela   Gabrielli Meri   Parlani Massimo   Bressan Alessandro   Maggi Carlo A.   Goso Cristina   Rotondaro Luigi  

Molecular Biotechnology, Vol. 23, Iss. 3, 2003-05 ,pp. : 189-202

Humana Press, Inc

Access to resources Recommend Favorite

A Novel Method for Modification of Tumor Cells with Bacterial Superantigen with a Heterobifunctional Cross-Linking Agent in Immunotherapy of Cancer

By Shimizu Motomu   Matsuzawa Akio   Takeda Yasutaka  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 89-94

Humana Press, Inc

Access to resources Recommend Favorite

Differential Gene Expression of Human CD34⁺ Hematopoietic Stem and Progenitor Cells Before and After Culture

By Li Qunliang   Cai Haibo   Liu Qiwei   Tan Wen-Song  

Biotechnology Letters, Vol. 28, Iss. 6, 2006-03 ,pp. : 389-394

Springer Publishing Company

Access to resources Recommend Favorite

Cancer/testis antigen cancer-associated gene (CAGE) promotes motility of cancer cells through activation of focal adhesion kinase (FAK)

By Shim Hyeeun   Lee Hansoo   Jeoung Dooil  

Biotechnology Letters, Vol. 28, Iss. 24, 2006-12 ,pp. : 2057-2063

Springer Publishing Company

Access to resources Recommend Favorite